CD34 and acute myeloid leukemia: Even though the target cells were made by expressing leukemic oncogenes in a healthy CD34 + human umbilical blood cord cell cultures, KGE02 showed no apparent shift in binding, which means the biomarker responsible for binding is only expressed on AML cells (Figs. 4, 5).